Atritech, Inc.

Atritech, Inc. (Atritech) is a clinical stage medical device company engaged in the development, manufacture and sales of medical products for cardiovascular markets. The company focuses on the development of minimally invasive technologies specifically designed for the prevention of atrial fibrillation related stroke. Its flagship product, the WATCHMAN left atrial appendage system is used for the treatment of patients suffering from atrial fibrillation. This system is permanently implanted through a catheter inside the left atrial appendage of the heart. The products offered by the company are certified with CE mark and approved by FDA. Atritech is headquartered in Minnesota, the US.

In January 2011, Boston Scientific Corporation entered into a definitive merger agreement with Atritech, under which Boston Scientific Corporation will acquire Atritech.

Street: 
3750 Annapolis Lane
City: 
Plymouth
Postcode: 
55447
Federal State : 
United States
WebSite: 
www.atritech.net
Fax: 
1-763-2580253

Company Index Score

Current Index Score Historical Index Score
  • Atritech, Inc. currently scores 50 % in the index.
  • Atritech, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Atritech, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets